Niemann-Pick Disease Drug Type C Treatment Market Witnesses High Growth due to Advancements in Therapeutic Drugs
Niemann-Pick disease Type C is a rare genetic lysosomal storage disorder that prevents cholesterol and other lipids from being processed and utilized properly by cells in the body. If left untreated, it can lead to progressive neurological dysfunction and early death. Currently, cerliponase alfa injection ( trade name Brineura) and miglustat (Zavesca) are the only approved treatments for this...
0 Commentarii 0 Distribuiri 972 Views 0 previzualizare
Sponsor